Metropolis Healthcare Limited has informed the Exchange about the update on acquisition
METROPOLIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Metropolis Healthcare's subsidiary, Scientific Metropolis Pathology Private Limited, has acquired the entire business of 'Dr. Ashok Kumar Sharma's Scientific Pathology', a sole proprietorship firm, as a going concern effective June 16, 2025. The deal was executed through a Business Transfer Agreement (BTA), with deferred consideration and other terms to be completed as per the BTA. This is a follow-up to the company's earlier intimation dated May 31, 2025, indicating a previously announced acquisition has now closed. The acquired operations will now be carried out under the subsidiary.
This is a small bolt-on acquisition by a subsidiary that strengthens Metropolis's pathology network through inorganic expansion. For shareholders, the financial impact is likely modest given the small scale, but it signals continued consolidation in the diagnostics space.